{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:26:31Z","timestamp":1784193991885,"version":"3.55.0"},"reference-count":31,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Kedrion Biopharma Inc","award":["Funding for this work was not provided through a g"],"award-info":[{"award-number":["Funding for this work was not provided through a g"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,3,24]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare the epidemiology of paediatric and adult patients receiving rabies immune globulin (RIG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional prevalence study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Eligible participants from the Symphony Integrated Dataverse presenting between 2013 and 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>All adult and paediatric patients with integrated claims and demographic data associated with RIG use from the Symphony Integrated Dataverse from 2013 to 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Prevalence of diagnoses and procedures associated with paediatric and adult patient population based on frequency of International Classification of Diseases (ICD-9\/ICD-10) and Current Procedural Terminology codes, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used mutual information to identify features that differentiate the paediatric from adult patient population. Prevalence ratios were calculated to compare adult and paediatric patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 79\u2009766 adult and 20\u2009381 paediatric patients who met the inclusion criteria. Paediatric patients had a 5.92-fold higher prevalence of \u2018open wounds to the head; neck; and trunk\u2019, 3.10-fold higher prevalence of \u2018abrasion or friction burn of face; neck; and scalp except eye; without mention of infection\u2019, 4.44-fold higher prevalence of \u2018open wound of scalp; without mention of complication\u2019 and 6.75-fold higher prevalence of \u2018laceration of skin of eyelid and periocular area | laceration of eyelid involving lacrimal passages\u2019. Paediatric patients had a 3.83-fold higher prevalence of complex repairs compared with adult patients (n=157, 0.7% vs n=157, 0.2%, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Paediatric patients represent a significant proportion of the patient population receiving RIG, and are associated with higher prevalence of codes reporting repair of larger, more complex wounds in highly innervated anatomical regions. Dosing and administration of RIG must be informed by animal bite wound characteristics; clinicians should understand the differences between presentations in adults and children and treat accordingly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-055411","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:11:08Z","timestamp":1652775068000},"page":"e055411","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-558X","authenticated-orcid":false,"given":"Rita V","family":"Burke","sequence":"first","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierantonio","family":"Russo","sequence":"additional","affiliation":[{"name":"Eversana Life Science Services, Milwaukee (HQ), Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sicilia","sequence":"additional","affiliation":[{"name":"Eversana Life Science Services, Milwaukee (HQ), Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wolowich","sequence":"additional","affiliation":[{"name":"Nova Southeastern University, Fort Lauderdale, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novinyo","family":"Amega","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Kedrion Biopharma, Fort Lee, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy-Binh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Kedrion Biopharma, Fort Lee, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2025121509004671000_12.4.e055411.1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5888-5"},{"key":"2025121509004671000_12.4.e055411.2","unstructured":"World Health Organization . Rabies, 2020. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rabies [Accessed 26 Feb 2021]."},{"key":"2025121509004671000_12.4.e055411.3","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.ijid.2011.03.023","article-title":"Clinical and epidemiological features of human rabies cases in the Philippines: a review from 1987 to 2006","volume":"15","author":"Dimaano","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2025121509004671000_12.4.e055411.4","first-page":"1","article-title":"Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2025121509004671000_12.4.e055411.5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/zph.12706","article-title":"Post-Exposure rabies prophylaxis for mass bat exposures: case series and systematic review","volume":"67","author":"Choe","year":"2020","journal-title":"Zoonoses Public Health"},{"key":"2025121509004671000_12.4.e055411.6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/21645515.2019.1632680","article-title":"Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis","volume":"16","author":"Hwang","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"2025121509004671000_12.4.e055411.7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2460\/javma.245.10.1111","article-title":"Rabies surveillance in the United States during 2013","volume":"245","author":"Dyer","year":"2014","journal-title":"J Am Vet Med Assoc"},{"key":"2025121509004671000_12.4.e055411.8","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.228"},{"key":"2025121509004671000_12.4.e055411.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087357","article-title":"Mutual information between discrete and continuous data sets","volume":"9","author":"Ross","year":"2014","journal-title":"PLoS One"},{"key":"2025121509004671000_12.4.e055411.10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10005-1410","article-title":"Animal bite injuries in children: review of literature and case series","volume":"10","author":"Agrawal","year":"2017","journal-title":"Int J Clin Pediatr Dent"},{"key":"2025121509004671000_12.4.e055411.11","doi-asserted-by":"publisher","DOI":"10.1136\/injuryprev-2017-042621"},{"key":"2025121509004671000_12.4.e055411.12","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.onehlt.2020.100154","article-title":"Profiling the public health risk of canine rabies transmission in Kogi state, Nigeria","volume":"10","author":"Okeme","year":"2020","journal-title":"One Health"},{"key":"2025121509004671000_12.4.e055411.13","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2001.218.1923"},{"key":"2025121509004671000_12.4.e055411.14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S1481803500014494","article-title":"Dog bites in Canadian children: a five-year review of severity and emergency department management","volume":"7","author":"Lang","year":"2005","journal-title":"CJEM"},{"key":"2025121509004671000_12.4.e055411.15","first-page":"66","article-title":"Profile of animal bite cases in Pune","volume":"37","author":"Shetty","year":"2005","journal-title":"J Commun Dis"},{"key":"2025121509004671000_12.4.e055411.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001391"},{"key":"2025121509004671000_12.4.e055411.17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/01676830.2018.1470190","article-title":"Dog bite injuries of the eye and ocular adnexa","volume":"38","author":"Erickson","year":"2019","journal-title":"Orbit"},{"key":"2025121509004671000_12.4.e055411.18","doi-asserted-by":"publisher","DOI":"10.1038\/nature16033"},{"key":"2025121509004671000_12.4.e055411.19","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.105"},{"key":"2025121509004671000_12.4.e055411.20","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1080\/21645515.2020.1854000","article-title":"Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure","volume":"17","author":"Hobart-Porter","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025121509004671000_12.4.e055411.21","doi-asserted-by":"publisher","DOI":"10.2460\/javma.233.6.884"},{"key":"2025121509004671000_12.4.e055411.22","doi-asserted-by":"publisher","DOI":"10.2460\/javma.256.2.195"},{"key":"2025121509004671000_12.4.e055411.23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.15585\/mmwr.mm6823e1","article-title":"Vital Signs: Trends in Human Rabies Deaths and Exposures - United States, 1938-2018","volume":"68","author":"Pieracci","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025121509004671000_12.4.e055411.24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/2373379918768329","article-title":"Human rabies postexposure prophylaxis knowledge and retention among health professionals by using an online continuing education module: Arizona, 2012 to 2015","volume":"5","author":"Venkat","year":"2019","journal-title":"Pedagogy Health Promot"},{"key":"2025121509004671000_12.4.e055411.25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-113"},{"key":"2025121509004671000_12.4.e055411.26","first-page":"1","volume-title":"Recommendations of the Advisory Committee on immunization practices (ACIP)","volume":"48(Rr-1)","year":"1999"},{"key":"2025121509004671000_12.4.e055411.27","first-page":"303","article-title":"Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects","volume":"45","author":"Cabasso","year":"1971","journal-title":"Bull World Health Organ"},{"key":"2025121509004671000_12.4.e055411.28","unstructured":"Grifols Therapeutics LLC . HYPERRAB [package insert]. Research Triangle Park (NC): Grifols Therapeutics LLC, 2018."},{"key":"2025121509004671000_12.4.e055411.29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jemermed.2004.02.005","article-title":"The use of rabies immune globulin by emergency physicians","volume":"27","author":"Jerrard","year":"2004","journal-title":"J Emerg Med"},{"key":"2025121509004671000_12.4.e055411.30","doi-asserted-by":"crossref","first-page":"A128","DOI":"10.1016\/j.vaccine.2019.07.087","article-title":"Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by \"pooling strategy\"","volume":"37 Suppl 1","author":"Bharti","year":"2019","journal-title":"Vaccine"},{"key":"2025121509004671000_12.4.e055411.31","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.38.2000018","article-title":"Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings","volume":"25","author":"Schreuder","year":"2020","journal-title":"Euro Surveill"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-055411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:01:04Z","timestamp":1765818064000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-055411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-055411"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-055411","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}